| Speakers |
|
Frans Claas, Ph.D, is director of the Eurotransplant Reference Laboratory and professor "Immunogenetics of transplantation" at the Leiden University Medical Center in Leiden, the Netherlands. During his university study in biochemistry, he became interested in transplantation immunology during a one year project at the department of Immunohaematology and Blood Transfusion headed by Jon van Rood, the founder of Eurotransplant. In 1976 he joined the group of van Rood and since that time he has combined his work in the histocompatibility laboratory with research in the field of transplantation immunology. The main topics of his research are the differential immunogenicity of HLA mismatches in clinical transplantation and immune mechanisms leading to transplantation tolerance. The studies of his group have generated more than 400 papers in peer-reviewed journals. He was the initiator of a special program within Eurotransplant to enhance transplantation of highly sensitized patients on basis of acceptable HLA mismatches. He is an active member of different immunogenetic societies as reflected by his past-presidency of the European Federation for Immunogenetics (EFI) and membership of the Board of the American Society for Histocompatibilty and Immunogenetics (ASHI). In the field of transplantion he is active as president of Europdonor and member of the boards of Eurotransplant, the Dutch Transplantation Society and Eurocord.
Dr. Thomas Coffman is James R. Clapp Professor of Medicine, Chief of the Division of Nephrology, Senior Vice-Chair in the Department of Medicine, and Co-Director of the Edna and Fred L. Mandel Center for Hypertension and Atherosclerosis Research at Duke University Medical Center. Dr. Coffman graduated from the University of Pennsylvania and obtained his M.D. from the Ohio State University School of Medicine. He undertook his internal medicine and nephrology training at Duke. A national leader in the field of nephrology, Dr. Coffman is currently the President of the American Society of Nephrology. He is also a member of the American Society for Clinical Investigation and the Association of American Physicians, and is a past-member of the Nephrology Subspecialty Board of the American Board of Internal Medicine. He serves on editorial boards for several scientific journals including Physiological Reviews and Cell Metabolism. Dr. Coffman is a Fellow of the Councils for High Blood Pressure Research and the Kidney in Cardiovascular Disease of the American Heart Association, and serves on the Leadership Committee for the AHA Council for High Blood Pressure Research. He is a member of scientific advisory boards for several pharmaceutical and biotech companies. Dr. Coffman’s research interests include the renin-angiotensin and prostanoid systems, studying their role in regulating blood pressure, kidney function, and renal inflammation. He is a member of the NIH-funded Animal Models of Diabetes Complications Consortium and his laboratory receives support from the NIH and the Department of Veterans’ Affairs.
Dr Levin is a Professor of Medicine at University of BC, Co-director of the Clinical Investigator Program at UBC and is the Executive director of the BC Provincial Renal Agency, an organization which manages and co-ordinates the care of patients with kidney disease in the province of BC. She received her undergraduate training at University of Toronto, medicine training at McMaster University and her post graduate nephrology and research training at the University of Toronto. She is the past Chair of the Kidney Foundation of Canada Biomedical Fellowship and Scholarship Committee, and serves as Chair of the Curriculum Committee for a new innovative program for the training of Canadian clinical scientists in kidney disease (KRESCENT). In addition she has served as past chair of the NKF KDOQI guideline process, and is on the Board of Directors and Executive committee of KDIGO. She has been recently appointed Secretary General of the ISN, and co-chair of the scientific program committee for the World Congress 2011. In addition she serves on the editorial boards for NDT, AJKD, JASN and CJASN, as well as reviewing for numerous journals including PDI, KI, AJKD, JASN, Circulation, Annals of Internal Medicine, Lancet and New England Journal of Medicine regularly. She has over 170 publications in peer reviewed journals. Her research and clinical activities focus on chronic kidney disease, co morbidities associated with CKD, mechanisms of disease and health outcomes research. She is active in mentoring young investigators in kidney related research, and holds numerous grants for clinical studies in the area of CKD. He is a member of the NIH-funded Animal Models of Diabetes Complications Consortium and his laboratory receives support from the NIH and the Department of Veterans’ Affairs.
Professor and Senior Lecturer Department of Clinical Science, Intervention and Technology Karolinska Institutet Stockholm Peter Stenvinkel is Professor and Senior Lecturer, Department of Renal Medicine Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden. He was a visiting Associate Professor at University of Davis California 2000-2001. He conducts his research at the Department of Department of Clinical Science, Intervention and Technology, Karolinska Institutet, and his research interest focuses on various aspects of metabolic disorders, genetics, epigenetics and risk factors for protein-energy wasting and cardiovascular disease in patients with chronic kidney disease. He has published over 270 peer-reviewed papers and numerous book chapters on various aspects of inflammation, wasting and metabolism in ESKD. He is on the Editorial Board for several Nephrological journals, the Faculty of 1000 and a member of several Nephrological societies. He has given more than 140 invited lectures at international meetings and congresses. |
Professor Frans H. J. Claas
Professor Thomas M. Coffman
Dr Adeera Levin 
Key Dates
Call for Abstracts Opens:
1 March 2010
Call for Abstracts Closes:
30 April 2010
Registration Opens:
March 2010
